Stock Analysis, Dividends, Split History

NVET / Nexvet Biopharma plc financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price6.72
Volume33,400.00
Market Cap ($M)80.08
Enterprise Value ($M)65.56
Book Value ($M)20.91
Book Value / Share1.76
Price / Book3.83
NCAV ($M)15.13
NCAV / Share1.27
Price / NCAV5.29
Share Statistics
Common Shares Outstanding 11,703,365
Common Stock Shares Outstanding 11,565,133
Deferred Stock Shares Outstanding 400
Scoring Models
Piotroski F-Score0.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.55
Return on Assets (ROA)-0.34
Return on Equity (ROE)-0.36
Balance Sheet (mrq) ($M)
Assets24.75
Liabilities3.83
Quick Ration/a
Current Ratio5.33
Income Statement (mra) ($M)
Operating Income-22.17
Net Income-19.36
Cash Flow Statement (mra) ($M)
Cash From Operations-14.78
Cash from Investing-4.99
Cash from Financing-14.78
Identifiers and Descriptors
CUSIPG6503X109
Central Index Key (CIK)1618561

Split History

Stock splits are used by Nexvet Biopharma plc to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon
CUSIP: G6503X109